Compare BHV & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHV | VVOS |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0M | 15.1M |
| IPO Year | 2002 | 2020 |
| Metric | BHV | VVOS |
|---|---|---|
| Price | $10.67 | $1.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 3.8K | ★ 77.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,031,000.00 |
| Revenue This Year | N/A | $31.42 |
| Revenue Next Year | N/A | $49.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.91 |
| 52 Week Low | $9.96 | $1.28 |
| 52 Week High | $11.66 | $7.40 |
| Indicator | BHV | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 38.24 |
| Support Level | $10.64 | N/A |
| Resistance Level | $10.69 | $1.88 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 6.12 | 17.01 |
Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.